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Methods: We report the 20-year FU of 912 patients (pts) who had good
immediate results (IR) of PMC (valve area -1.5cm² with mitral regurgitation
-2/4). Mean age was 48±13 yrs, 251 pts (27%) had calcified valves.
Results: During a mean FU of 12 years, 351 pts (38%) required a repeat
intervention on the mitral valve. Surgery was performed in 266 pts (76%). A
repeat PMC could be performed in 85 pts (24%) a mean of 10±4 years after
the first PMC, with good IR in 80 pts (94%).
Survival without re-intervention was 38±2% at 20 years. When considering
surgery alone, the corresponding rate increased to 46±2% at 20 years. In the
504 pts aged <50 years at their first PMC, 20-year rates were 45±3% for sur-
vival without re-intervention and 57±3% for survival without surgery (Figure).
Conclusion: After successful PMC 1) Re-intervention is frequently needed
during long-term FU 2) Repeat PMC can be performed in one out of 4 pts
needing re-intervention. 3) Surgery can thus be further postponed in a substan-
tial number of patients. 4) The favourable impact of repeat PMC is particu-
larly marked in pts aged <50 years, enabling more than half of them to remain
free from surgery 20 years after initial PMC.
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Introduction: Early repolarization (ER) has been recently linked with
idiopathic ventricular fibrillation. In spite of a frequent familial past history of
SCD, ER identification in relatives is limited by variability of the ER over the
time and with the variation of autonomic tone and heart rate. The aim of the
study was to test the ability of valsalva maneuver (VM) to identify larges fam-
ilies affected by early repolarization syndrome (ERS).
Methods: We have screened relatives of 2 families in which SCD occurred
with ERS. Patients were considered to be affected in the presence of a positive
deflection on the S wave in two consecutive leads and at least a 1 mm ampli-
tude above baseline. A VM was performed in relatives to increase or reveal
ER. Comparison between heart rate and J wave amplitude before and after
VM was performed with a paired Student's t-test.
Results: VM was performed for 80 relatives. It increased ER amplitude in
17/20 (85%) affected patients and revealed ER in 17/60 (28%) patients unaf-
fected at rest. VM succeeded in unmasking pattern for 5/11 (45%) expected
carrier of ER previously considered as unaffected. Heart rate at rest was
75±13 bpm and decreased of 3,9±7,9 bpm (p<0,001) during the test without
any difference between groups.
In the first family, 4 SCD occured whose one with an ER pattern. We iden-
tified 25 other ER out of 82 available ECG (prevalence 34%).
In the second family, 4 SCD occurred whose one with an ER pattern. We
identified 17 other ER out of 29 available ECG (prevalence 58%).
In those families, ER is transmitted with an autosomal dominant trait
through respectively 5 and 4 generations.
Conclusion: Malignant forms of ER can be transmitted as an autosomal
dominant trait in large families. VM could be helpful to unmask ER for
familial screening of relatives. Further investigations are required to assess
prognosis of VM.
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Purpose: Recent trials have provided worrying safety data on certain oral
hypoglycemic drugs. The aim of this study was to assess 14-year risk of all-
cause mortality according to hypoglycemic drug exposure at baseline, in a
general population.
Methods: Our analysis was based on the Third French MONICA survey
(1995-1996). Participants aged 35-64 were randomly recruited from the gen-
eral population of three French areas. Vital status was obtained 14 years after
inclusion, and assessment of determinants of mortality was based on multi-
variable Cox modelling.
Results: There were 3403 participants and 272 deaths over the 14-year
period. At baseline, there were 3220 (95%) non-diabetic subjects, 48 (1%)
untreated diabetics and 135 (4%) diabetics with hypoglycemic drug treatment
(metformin alone (30%), sulfonylurea alone or in combination with other
hypoglycemic drugs except insulin (48%), insulin alone or in combination
with other hypoglycemic drugs except sulfonylurea (13%), other treatments
(9%)). Death rate was 7%, 23% and 21% in non-diabetic subjects, untreated
diabetics and diabetics with hypoglycemic drugs, respectively. A multivariate
analysis was performed with adjustment for duration of diabetes, history of
diabetes complications or severe chronic disease, and living area, age, gender,
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